These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6336551)

  • 21. Hyperthermia in the pediatric intensive care unit--is it malignant hyperthermia?
    Schleelein LE; Litman RS
    Paediatr Anaesth; 2009 Nov; 19(11):1113-8. PubMed ID: 19694974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
    Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of caffeine-halothane contracture test in the diagnosis of malignant hyperthermia].
    Wang YL; Guo XY; Xu ZH; Huang YG; Luo AL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):182-6. PubMed ID: 18505122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for malignant hyperpyrexia.
    Nelson TE; Austin KL; Denborough MA
    Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contracture test with ionophore A 23187 for the diagnosis of malignant hyperthermia].
    Moeller R; Kozak-Reiss G; Gascard JP; Laxenaire MC
    Ann Fr Anesth Reanim; 1986; 5(2):177-81. PubMed ID: 3089080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.
    Isaacs H; Badenhorst M
    Anesthesiology; 1993 Jul; 79(1):5-9. PubMed ID: 8342829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salicylate toxicity masquerading as malignant hyperthermia.
    Candy JM; Morrison C; Paton RD; Logan RW; Lawson R
    Paediatr Anaesth; 1998; 8(5):421-3. PubMed ID: 9742539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant hyperthermia in a halothane-anesthetized horse.
    Waldron-Mease E; Klein LV; Rosenberg H; Leitch M
    J Am Vet Med Assoc; 1981 Nov; 179(9):896-8. PubMed ID: 7341603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium uptake in frozen muscle biopsy sections compared with other predictors of malignant hyperthermia susceptibility.
    Nagarajan K; Fishbein WN; Muldoon SM; Pezeshkpour G
    Anesthesiology; 1987 May; 66(5):680-5. PubMed ID: 3578882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro diagnosis of malignant hyperthermia: influence of electrical stimulation on the contracture response to caffeine.
    Heytens L; Martin JJ; Bossaert LL
    Br J Anaesth; 1992 Jul; 69(1):87-91. PubMed ID: 1637610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
    Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
    Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
    Urwyler A; Censier K; Kaufmann MA; Drewe J
    Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
    Weglinski MR; Wedel DJ; Engel AG
    Anesth Analg; 1997 May; 84(5):1038-41. PubMed ID: 9141928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for related myopathies in exertional heat stroke and malignant hyperthermia.
    Hopkins PM; Ellis FR; Halsall PJ
    Lancet; 1991 Dec; 338(8781):1491-2. PubMed ID: 1683922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
    Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
    Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteogenesis imperfecta and malignant hyperthermia. Is there a relationship?
    Porsborg P; Astrup G; Bendixen D; Lund AM; Ording H
    Anaesthesia; 1996 Sep; 51(9):863-5. PubMed ID: 8882252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.